{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T20:39:46Z","timestamp":1795034386329,"version":"4.10.2"},"reference-count":135,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100010969","name":"Alzheimer Nederland","doi-asserted-by":"publisher","award":["WE.03-2020-02"],"award-info":[{"award-number":["WE.03-2020-02"]}],"id":[{"id":"10.13039\/501100010969","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Stichting LSH-TKI PPP","award":["S-000438"],"award-info":[{"award-number":["S-000438"]}]},{"name":"Stichting LSH-TKI PPP","award":["S-000438"],"award-info":[{"award-number":["S-000438"]}]},{"name":"Stichting LSH-TKI PPP","award":["S-000438"],"award-info":[{"award-number":["S-000438"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The hippocampus is highly affected in neurodegenerative diseases, including Alzheimer\u2019s disease (AD) and Parkinson\u2019s disease (PD). The relationship between neuropathology and atrophy in hippocampal subfields is complex due to differences in the selective neuronal vulnerability to distinct protein aggregates that underlie cognitive impairment. The aim of the current study was to investigate the relation between hippocampal subfield volumes, neuropathological burden (amyloid-\u03b2, p-tau and \u03b1-synuclein) and cognitive performance in AD, PD and control brain donors, using a cross-disease and within-subject post-mortem in situ MRI and neuropathology approach.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A total of 60 brain donors, including 14 non-neurological controls, 27 AD and 19 PD, underwent post-mortem in situ MRI. From 3D-T1 images hippocampal subfield and entorhinal cortex volumes were derived using FreeSurfer-based subfield segmentation. Hippocampal tissue was obtained at subsequent autopsy, fixed and immunostained for amyloid-\u03b2, p-tau and pSer129-\u03b1Syn. Immunoreactivity in hippocampal subfields was quantified as area% load using QuPath. Clinical Dementia Rating scores were extracted from the clinical files when available.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>AD showed atrophy and increased p-tau, but not amyloid-\u03b2, burden in the CA1, subiculum and entorhinal cortex compared to controls, however MRI and neuropathology did not correlate. Controls and PD had similar hippocampal subfield volumes and pathology load. In PD, p-tau pathology, rather than pSer129-\u03b1Syn, was associated with lower total hippocampal volume (<jats:italic>r<\/jats:italic>=-0.68, <jats:italic>p<\/jats:italic>\u2009=\u20090.045), predominantly in PD with dementia (PDD) (<jats:italic>r<\/jats:italic>=-0.99, <jats:italic>p<\/jats:italic>\u2009=\u20090.013). Cross-disease, volume loss of the subiculum (<jats:italic>r=-<\/jats:italic>0.68, <jats:italic>p\u2009=<\/jats:italic>\u20090.001) and entorhinal cortex (<jats:italic>r=-<\/jats:italic>0.73, <jats:italic>p\u2009=<\/jats:italic>\u20090.004) strongly associated with cognitive impairment. Moreover, p-tau pathology had the strongest effect on subfield atrophy, most pronounced in the subiculum (<jats:italic>\u03b2=-0.570<\/jats:italic>, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), but could only explain 22\u201344% of the volumetric variance.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Even though p-tau was the strongest predictor of hippocampal subfield atrophy, AD-pathology (p-tau and amyloid-\u03b2) only partially accounted for volumetric differences in hippocampal subfields, highlighting the significance of other pathologies or mechanisms. The increased sensitivity of subicular and entorhinal cortical atrophy compared to total hippocampal atrophy highlights the potential clinical value of incorporating hippocampal subfield atrophy in monitoring disease progression.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13195-025-01768-w","type":"journal-article","created":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T06:54:11Z","timestamp":1748588051000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Hippocampal subfields: volume, neuropathological vulnerability and cognitive decline in Alzheimer\u2019s and Parkinson\u2019s disease"],"prefix":"10.1186","volume":"17","author":[{"given":"Maud M. A.","family":"Bouwman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Frigerio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Pei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels","family":"Reijner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilma D. J.","family":"van de Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura E.","family":"Jonkman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,30]]},"reference":[{"key":"1768_CR1","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.nicl.2016.12.008","volume":"14","author":"H Foo","year":"2017","unstructured":"Foo H, Mak E, Chander RJ, Ng A, Au WL, Sitoh YY, et al. Associations of hippocampal subfields in the progression of cognitive decline related to Parkinson\u2019s disease. Neuroimage Clin. 2017;14:37\u201342.","journal-title":"Neuroimage Clin"},{"issue":"9","key":"1768_CR2","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1002\/hbm.20934","volume":"31","author":"SG Mueller","year":"2010","unstructured":"Mueller SG, Schuff N, Yaffe K, Madison C, Miller B, Weiner MW. Hippocampal atrophy patterns in mild cognitive impairment and Alzheimer\u2019s disease. Hum Brain Mapp. 2010;31(9):1339\u201347.","journal-title":"Hum Brain Mapp"},{"issue":"5","key":"1768_CR3","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1212\/WNL.58.5.750","volume":"58","author":"CR Jack","year":"2002","unstructured":"Jack CR, Dickson DW, Parisi JE, Xu YC, Cha RH, O\u2019Brien PC, et al. Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia. Neurology. 2002;58(5):750\u20137.","journal-title":"Neurology"},{"issue":"5","key":"1768_CR4","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1001\/archneur.63.5.693","volume":"63","author":"LG Apostolova","year":"2006","unstructured":"Apostolova LG, Dutton RA, Dinov ID, Hayashi KM, Toga AW, Cummings JL, et al. Conversion of mild cognitive impairment to alzheimer disease predicted by hippocampal atrophy maps. Arch Neurol. 2006;63(5):693\u20139.","journal-title":"Arch Neurol"},{"issue":"7","key":"1768_CR5","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1002\/mds.10444","volume":"18","author":"R Camicioli","year":"2003","unstructured":"Camicioli R, Moore MM, Kinney A, Corbridge E, Glassberg K, Kaye JA. Parkinson\u2019s disease is associated with hippocampal atrophy. Mov Disord. 2003;18(7):784\u201390.","journal-title":"Mov Disord"},{"issue":"4","key":"1768_CR6","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/j.neuroimage.2010.03.018","volume":"51","author":"KK Leung","year":"2010","unstructured":"Leung KK, Barnes J, Ridgway GR, Bartlett JW, Clarkson MJ, Macdonald K, et al. Automated cross-sectional and longitudinal hippocampal volume measurement in mild cognitive impairment and Alzheimer\u2019s disease. NeuroImage. 2010;51(4):1345\u201359.","journal-title":"NeuroImage"},{"issue":"11","key":"1768_CR7","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1212\/01.wnl.0000344568.09360.31","volume":"72","author":"W Henneman","year":"2009","unstructured":"Henneman W, Sluimer J, Barnes J, Van Der Flier W, Sluimer I, Fox N, et al. Hippocampal atrophy rates in alzheimer disease: added value over whole brain volume measures. Neurology. 2009;72(11):999\u20131007.","journal-title":"Neurology"},{"issue":"8","key":"1768_CR8","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/j.neurobiolaging.2007.02.011","volume":"29","author":"J Barnes","year":"2008","unstructured":"Barnes J, Scahill R, Frost C, Schott J, Rossor M, Fox N. Increased hippocampal atrophy rates in AD over 6 months using serial MR imaging. Neurobiol Aging. 2008;29(8):1199\u2013203.","journal-title":"Neurobiol Aging"},{"key":"1768_CR9","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.neuroscience.2015.08.033","volume":"309","author":"R de Flores","year":"2015","unstructured":"de Flores R, La Joie R, Chetelat G. Structural imaging of hippocampal subfields in healthy aging and Alzheimer\u2019s disease. Neuroscience. 2015;309:29\u201350.","journal-title":"Neuroscience"},{"issue":"10","key":"1768_CR10","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/nrn3085","volume":"12","author":"SA Small","year":"2011","unstructured":"Small SA, Schobel SA, Buxton RB, Witter MP, Barnes CA. A pathophysiological framework of hippocampal dysfunction in ageing and disease. Nat Rev Neurosci. 2011;12(10):585\u2013601.","journal-title":"Nat Rev Neurosci"},{"issue":"2","key":"1768_CR11","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jalz.2015.01.001","volume":"11","author":"LG Apostolova","year":"2015","unstructured":"Apostolova LG, Zarow C, Biado K, Hurtz S, Boccardi M, Somme J, et al. Relationship between hippocampal atrophy and neuropathology markers: a 7T MRI validation study of the EADC-ADNI harmonized hippocampal segmentation protocol. Alzheimers Dement. 2015;11(2):139\u201350.","journal-title":"Alzheimers Dement"},{"key":"1768_CR12","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.nicl.2013.08.007","volume":"3","author":"R La Joie","year":"2013","unstructured":"La Joie R, Perrotin A, de La Sayette V, Egret S, Doeuvre L, Belliard S, et al. Hippocampal subfield volumetry in mild cognitive impairment, Alzheimer\u2019s disease and semantic dementia. Neuroimage Clin. 2013;3:155\u201362.","journal-title":"Neuroimage Clin"},{"issue":"1","key":"1768_CR13","doi-asserted-by":"publisher","first-page":"220","DOI":"10.21037\/qims.2019.10.17","volume":"10","author":"R Xu","year":"2020","unstructured":"Xu R, Hu X, Jiang X, Zhang Y, Wang J, Zeng X. Longitudinal volume changes of hippocampal subfields and cognitive decline in Parkinson\u2019s disease. Quant Imaging Med Surg. 2020;10(1):220\u201332.","journal-title":"Quant Imaging Med Surg"},{"issue":"4","key":"1768_CR14","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00401-006-0127-z","volume":"112","author":"H Braak","year":"2006","unstructured":"Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K. Staging of alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol. 2006;112(4):389\u2013404.","journal-title":"Acta Neuropathol"},{"issue":"2","key":"1768_CR15","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1093\/jnen\/nlz123","volume":"79","author":"H Braak","year":"2020","unstructured":"Braak H, Del Tredici K. From the entorhinal region via the prosubiculum to the dentate fascia: alzheimer Disease-Related neurofibrillary changes in the Temporal allocortex. J Neuropathol Exp Neurol. 2020;79(2):163\u201375.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"12","key":"1768_CR16","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1212\/WNL.58.12.1791","volume":"58","author":"DR Thal","year":"2002","unstructured":"Thal DR, Rub U, Orantes M, Braak H. Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology. 2002;58(12):1791\u2013800.","journal-title":"Neurology"},{"issue":"6","key":"1768_CR17","doi-asserted-by":"publisher","first-page":"e27429","DOI":"10.1016\/j.heliyon.2024.e27429","volume":"10","author":"M Punzi","year":"2024","unstructured":"Punzi M, Sestieri C, Picerni E, Chiarelli AM, Padulo C, Delli Pizzi A, et al. Atrophy of hippocampal subfields and amygdala nuclei in subjects with mild cognitive impairment progressing to Alzheimer\u2019s disease. Heliyon. 2024;10(6):e27429.","journal-title":"Heliyon"},{"issue":"Pt 10","key":"1768_CR18","doi-asserted-by":"publisher","first-page":"2814","DOI":"10.1093\/brain\/awv236","volume":"138","author":"H Braak","year":"2015","unstructured":"Braak H, Del Tredici K. The preclinical phase of the pathological process underlying sporadic Alzheimer\u2019s disease. Brain. 2015;138(Pt 10):2814\u201333.","journal-title":"Brain"},{"issue":"12","key":"1768_CR19","doi-asserted-by":"publisher","first-page":"3286","DOI":"10.1093\/brain\/awx243","volume":"140","author":"A Bejanin","year":"2017","unstructured":"Bejanin A, Schonhaut DR, La Joie R, Kramer JH, Baker SL, Sosa N, et al. Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer\u2019s disease. Brain. 2017;140(12):3286\u2013300.","journal-title":"Brain"},{"issue":"9","key":"1768_CR20","doi-asserted-by":"publisher","first-page":"2771","DOI":"10.1093\/brain\/awab114","volume":"144","author":"D Berron","year":"2021","unstructured":"Berron D, Vogel JW, Insel PS, Pereira JB, Xie L, Wisse LEM, et al. Early stages of Tau pathology and its associations with functional connectivity, atrophy and memory. Brain. 2021;144(9):2771\u201383.","journal-title":"Brain"},{"issue":"1","key":"1768_CR21","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41593-018-0289-8","volume":"22","author":"MA Busche","year":"2019","unstructured":"Busche MA, Wegmann S, Dujardin S, Commins C, Schiantarelli J, Klickstein N, et al. Tau impairs neural circuits, dominating amyloid-beta effects, in alzheimer models in vivo. Nat Neurosci. 2019;22(1):57\u201364.","journal-title":"Nat Neurosci"},{"issue":"2","key":"1768_CR22","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging. 2003;24(2):197\u2013211.","journal-title":"Neurobiol Aging"},{"issue":"8","key":"1768_CR23","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1212\/01.WNL.0000158422.41380.82","volume":"64","author":"H Braak","year":"2005","unstructured":"Braak H, Rub U, Jansen Steur EN, Del Tredici K, de Vos RA. Cognitive status correlates with neuropathologic stage in Parkinson disease. Neurology. 2005;64(8):1404\u201310.","journal-title":"Neurology"},{"issue":"2","key":"1768_CR24","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s00702-013-1084-z","volume":"121","author":"RA Armstrong","year":"2014","unstructured":"Armstrong RA, Kotzbauer PT, Perlmutter JS, Campbell MC, Hurth KM, Schmidt RE, et al. A quantitative study of alpha-synuclein pathology in fifteen cases of dementia associated with Parkinson disease. J Neural Transm (Vienna). 2014;121(2):171\u201381.","journal-title":"J Neural Transm (Vienna)"},{"issue":"6","key":"1768_CR25","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1212\/WNL.49.6.1570","volume":"49","author":"A Churchyard","year":"1997","unstructured":"Churchyard A, Lees AJ. The relationship between dementia and direct involvement of the hippocampus and amygdala in Parkinson\u2019s disease. Neurology. 1997;49(6):1570\u20136.","journal-title":"Neurology"},{"issue":"3","key":"1768_CR26","first-page":"141","volume":"42","author":"E Bertrand","year":"2004","unstructured":"Bertrand E, Lechowicz W, Szpak GM, Lewandowska E, Dymecki J, Wierzba-Bobrowicz T. Limbic neuropathology in idiopathic Parkinson\u2019s disease with concomitant dementia. Folia Neuropathol. 2004;42(3):141\u201350.","journal-title":"Folia Neuropathol"},{"key":"1768_CR27","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1159\/000356430","volume":"34","author":"KK Moodley","year":"2014","unstructured":"Moodley KK, Chan D. The hippocampus in neurodegenerative disease. Front Neurol Neurosci. 2014;34:95\u2013108.","journal-title":"Front Neurol Neurosci"},{"issue":"24","key":"1768_CR28","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1212\/01.wnl.0000271090.28148.24","volume":"69","author":"JA Schneider","year":"2007","unstructured":"Schneider JA, Arvanitakis Z, Bang W, Bennett DA. Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology. 2007;69(24):2197\u2013204.","journal-title":"Neurology"},{"issue":"5","key":"1768_CR29","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.parkreldis.2014.02.012","volume":"20","author":"BN Dugger","year":"2014","unstructured":"Dugger BN, Adler CH, Shill HA, Caviness J, Jacobson S, Driver-Dunckley E, et al. Concomitant pathologies among a spectrum of parkinsonian disorders. Parkinsonism Relat Disord. 2014;20(5):525\u20139.","journal-title":"Parkinsonism Relat Disord"},{"issue":"1074","key":"1768_CR30","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1136\/postgradmedj-2015-133247","volume":"91","author":"J Cosgrove","year":"2015","unstructured":"Cosgrove J, Alty JE, Jamieson S. Cognitive impairment in Parkinson\u2019s disease. Postgrad Med J. 2015;91(1074):212\u201320.","journal-title":"Postgrad Med J"},{"issue":"12","key":"1768_CR31","doi-asserted-by":"publisher","first-page":"e209460","DOI":"10.1212\/WNL.0000000000209460","volume":"102","author":"R Ye","year":"2024","unstructured":"Ye R, Goodheart AE, Locascio JJ, Peterec E, Properzi M, Thibault EG, et al. Differential vulnerability of hippocampal subfields to amyloid and Tau deposition in the lewy body diseases. Neurology. 2024;102(12):e209460.","journal-title":"Neurology"},{"issue":"Pt 5","key":"1768_CR32","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1093\/brain\/awr031","volume":"134","author":"Y Compta","year":"2011","unstructured":"Compta Y, Parkkinen L, O\u2019Sullivan SS, Vandrovcova J, Holton JL, Collins C, et al. Lewy- and Alzheimer-type pathologies in Parkinson\u2019s disease dementia: which is more important? Brain. 2011;134(Pt 5):1493\u2013505.","journal-title":"Brain"},{"issue":"10","key":"1768_CR33","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1212\/01.wnl.0000324924.91351.7d","volume":"71","author":"JL Whitwell","year":"2008","unstructured":"Whitwell JL, Josephs KA, Murray ME, Kantarci K, Przybelski SA, Weigand SD, et al. MRI correlates of neurofibrillary tangle pathology at autopsy: a voxel-based morphometry study. Neurology. 2008;71(10):743\u20139.","journal-title":"Neurology"},{"issue":"15supplement","key":"1768_CR34","doi-asserted-by":"publisher","first-page":"4514","DOI":"10.1212\/WNL.96.15_supplement.4514","volume":"96","author":"N Bergsland","year":"2021","unstructured":"Bergsland N, Zivadinov R, Tosun-Turgut D, Weintraub D, Guttuso T. Hippocampal subfield volumetry for predicting cognitive impairment in Parkinson\u2019s disease (4514). Neurology. 2021;96(15supplement):4514.","journal-title":"Neurology"},{"issue":"1","key":"1768_CR35","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s40478-021-01275-7","volume":"9","author":"S Ravikumar","year":"2021","unstructured":"Ravikumar S, Wisse LEM, Lim S, Ittyerah R, Xie L, Bedard ML, et al. Ex vivo MRI atlas of the human medial Temporal lobe: characterizing neurodegeneration due to Tau pathology. Acta Neuropathol Commun. 2021;9(1):173.","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"1768_CR36","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s40478-021-01225-3","volume":"9","author":"LEM Wisse","year":"2021","unstructured":"Wisse LEM, Ravikumar S, Ittyerah R, Lim S, Lane J, Bedard ML, et al. Downstream effects of polypathology on neurodegeneration of medial Temporal lobe subregions. Acta Neuropathol Commun. 2021;9(1):128.","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"1768_CR37","doi-asserted-by":"publisher","first-page":"4803","DOI":"10.1038\/s41467-024-49205-0","volume":"15","author":"S Ravikumar","year":"2024","unstructured":"Ravikumar S, Denning AE, Lim S, Chung E, Sadeghpour N, Ittyerah R, et al. Postmortem imaging reveals patterns of medial Temporal lobe vulnerability to Tau pathology in Alzheimer\u2019s disease. Nat Commun. 2024;15(1):4803.","journal-title":"Nat Commun"},{"key":"1768_CR38","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.neurobiolaging.2018.10.013","volume":"74","author":"V Hanko","year":"2019","unstructured":"Hanko V, Apple AC, Alpert KI, Warren KN, Schneider JA, Arfanakis K, et al. In vivo hippocampal subfield shape related to TDP-43, amyloid beta, and Tau pathologies. Neurobiol Aging. 2019;74:171\u201381.","journal-title":"Neurobiol Aging"},{"issue":"3","key":"1768_CR39","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/S1474-4422(20)30440-3","volume":"20","author":"J Graff-Radford","year":"2021","unstructured":"Graff-Radford J, Yong KXX, Apostolova LG, Bouwman FH, Carrillo M, Dickerson BC, et al. New insights into atypical Alzheimer\u2019s disease in the era of biomarkers. Lancet Neurol. 2021;20(3):222\u201334.","journal-title":"Lancet Neurol"},{"key":"1768_CR40","doi-asserted-by":"publisher","first-page":"101698","DOI":"10.1016\/j.nicl.2019.101698","volume":"22","author":"LE Jonkman","year":"2019","unstructured":"Jonkman LE, Graaf YG, Bulk M, Kaaij E, Pouwels PJW, Barkhof F, et al. Normal aging brain collection Amsterdam (NABCA): A comprehensive collection of postmortem high-field imaging, neuropathological and morphometric datasets of non-neurological controls. Neuroimage Clin. 2019;22:101698.","journal-title":"Neuroimage Clin"},{"issue":"4","key":"1768_CR41","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991;82(4):239\u201359.","journal-title":"Acta Neuropathol"},{"issue":"3","key":"1768_CR42","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1093\/jnen\/61.3.282","volume":"61","author":"DR Thal","year":"2002","unstructured":"Thal DR, Ghebremedhin E, R\u00fcb U, Yamaguchi H, Del Tredici K, Braak H. Two types of sporadic cerebral amyloid angiopathy. J Neuropathology Experimental Neurol. 2002;61(3):282\u201393.","journal-title":"J Neuropathology Experimental Neurol"},{"issue":"6","key":"1768_CR43","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1093\/brain\/awz099","volume":"142","author":"PT Nelson","year":"2019","unstructured":"Nelson PT, Dickson DW, Trojanowski JQ, Jack CR, Boyle PA, Arfanakis K, et al. Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report. Brain. 2019;142(6):1503\u201327.","journal-title":"Brain"},{"key":"1768_CR44","doi-asserted-by":"crossref","unstructured":"Kautzky A, Seiger R, Hahn A, Fischer P, Krampla W, Kasper S et al. Prediction of autopsy verified neuropathological change of Alzheimer\u2019s disease using machine learning and MRI. Front Aging Neurosci. 2018;10:406.","DOI":"10.3389\/fnagi.2018.00406"},{"issue":"11","key":"1768_CR45","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1212\/WNL.43.11.2412-a","volume":"43","author":"JC Morris","year":"1993","unstructured":"Morris JC. The clinical dementia rating (CDR): current version and scoring rules. Neurology. 1993;43(11):2412\u20134.","journal-title":"Neurology"},{"issue":"2","key":"1768_CR46","doi-asserted-by":"publisher","first-page":"351","DOI":"10.2214\/ajr.149.2.351","volume":"149","author":"F Fazekas","year":"1987","unstructured":"Fazekas F, Chawluk J, Alavi A, Hurtig H, Zimmerman R. MR signal abnormalities at 1.5 T in Alzheimer\u2019s dementia and normal aging. Am J Roentgenol. 1987;149(2):351\u20136.","journal-title":"Am J Roentgenol"},{"key":"1768_CR47","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.nicl.2013.10.003","volume":"3","author":"MD Steenwijk","year":"2013","unstructured":"Steenwijk MD, Pouwels PJ, Daams M, van Dalen JW, Caan MW, Richard E, et al. Accurate white matter lesion segmentation by K nearest neighbor classification with tissue type priors (kNN-TTPs). Neuroimage Clin. 2013;3:462\u20139.","journal-title":"Neuroimage Clin"},{"issue":"4","key":"1768_CR48","doi-asserted-by":"publisher","first-page":"fcab281","DOI":"10.1093\/braincomms\/fcab281","volume":"3","author":"I Frigerio","year":"2021","unstructured":"Frigerio I, Boon BDC, Lin CP, Galis-de Graaf Y, Bol J, Preziosa P, et al. Amyloid-beta, p-tau and reactive microglia are pathological correlates of MRI cortical atrophy in Alzheimer\u2019s disease. Brain Commun. 2021;3(4):fcab281.","journal-title":"Brain Commun"},{"issue":"3","key":"1768_CR49","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.neuroimage.2006.01.021","volume":"31","author":"RS Desikan","year":"2006","unstructured":"Desikan RS, Segonne F, Fischl B, Quinn BT, Dickerson BC, Blacker D, et al. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. NeuroImage. 2006;31(3):968\u201380.","journal-title":"NeuroImage"},{"key":"1768_CR50","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.neuroimage.2015.04.042","volume":"115","author":"JE Iglesias","year":"2015","unstructured":"Iglesias JE, Augustinack JC, Nguyen K, Player CM, Player A, Wright M, et al. A computational atlas of the hippocampal formation using ex vivo, ultra-high resolution MRI: application to adaptive segmentation of in vivo MRI. NeuroImage. 2015;115:117\u201337.","journal-title":"NeuroImage"},{"issue":"Suppl 1","key":"1768_CR51","doi-asserted-by":"publisher","first-page":"S208","DOI":"10.1016\/j.neuroimage.2004.07.051","volume":"23","author":"SM Smith","year":"2004","unstructured":"Smith SM, Jenkinson M, Woolrich MW, Beckmann CF, Behrens TE, Johansen-Berg H, et al. Advances in functional and structural MR image analysis and implementation as FSL. NeuroImage. 2004;23(Suppl 1):S208\u201319.","journal-title":"NeuroImage"},{"issue":"1","key":"1768_CR52","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s40035-022-00328-8","volume":"12","author":"I Frigerio","year":"2023","unstructured":"Frigerio I, Laansma MA, Lin CP, Hermans EJM, Bouwman MMA, Bol J, et al. Neurofilament light chain is increased in the parahippocampal cortex and associates with pathological hallmarks in Parkinson\u2019s disease dementia. Transl Neurodegener. 2023;12(1):3.","journal-title":"Transl Neurodegener"},{"issue":"1","key":"1768_CR53","doi-asserted-by":"publisher","first-page":"16878","DOI":"10.1038\/s41598-017-17204-5","volume":"7","author":"P Bankhead","year":"2017","unstructured":"Bankhead P, Loughrey MB, Fernandez JA, Dombrowski Y, McArt DG, Dunne PD, et al. QuPath: open source software for digital pathology image analysis. Sci Rep. 2017;7(1):16878.","journal-title":"Sci Rep"},{"key":"1768_CR54","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.neuroimage.2013.08.067","volume":"84","author":"DH Adler","year":"2014","unstructured":"Adler DH, Pluta J, Kadivar S, Craige C, Gee JC, Avants BB, et al. Histology-derived volumetric annotation of the human hippocampal subfields in postmortem MRI. NeuroImage. 2014;84:505\u201323.","journal-title":"NeuroImage"},{"issue":"1","key":"1768_CR55","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc: Ser B (Methodol). 1995;57(1):289\u2013300.","journal-title":"J Roy Stat Soc: Ser B (Methodol)"},{"issue":"16","key":"1768_CR56","doi-asserted-by":"publisher","first-page":"4252","DOI":"10.1073\/pnas.1801093115","volume":"115","author":"DH Adler","year":"2018","unstructured":"Adler DH, Wisse LEM, Ittyerah R, Pluta JB, Ding SL, Xie L, et al. Characterizing the human hippocampus in aging and Alzheimer\u2019s disease using a computational atlas derived from ex vivo MRI and histology. Proc Natl Acad Sci U S A. 2018;115(16):4252\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1768_CR57","first-page":"11","volume":"18","author":"ED Bigler","year":"1997","unstructured":"Bigler ED, Blatter DD, Anderson CV, Johnson SC, Gale SD, Hopkins RO, et al. Hippocampal volume in normal aging and traumatic brain injury. AJNR Am J Neuroradiol. 1997;18(1):11\u201323.","journal-title":"AJNR Am J Neuroradiol"},{"key":"1768_CR58","doi-asserted-by":"publisher","first-page":"108190","DOI":"10.1155\/2010\/108190","volume":"2010","author":"AM Stranahan","year":"2010","unstructured":"Stranahan AM, Mattson MP. Selective vulnerability of neurons in layer II of the entorhinal cortex during aging and Alzheimer\u2019s disease. Neural Plast. 2010;2010:108190.","journal-title":"Neural Plast"},{"issue":"4667","key":"1768_CR59","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1126\/science.6474172","volume":"225","author":"BT Hyman","year":"1984","unstructured":"Hyman BT, Van Hoesen GW, Damasio AR, Barnes CL. Alzheimer\u2019s disease: Cell-Specific pathology isolates the hippocampal formation. Science. 1984;225(4667):1168\u201370.","journal-title":"Science"},{"issue":"5","key":"1768_CR60","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1093\/brain\/awp059","volume":"132","author":"G Lace","year":"2009","unstructured":"Lace G, Savva GM, Forster G, de Silva R, Brayne C, Matthews FE, et al. Hippocampal Tau pathology is related to neuroanatomical connections: an ageing population-based study. Brain. 2009;132(5):1324\u201334.","journal-title":"Brain"},{"key":"1768_CR61","doi-asserted-by":"publisher","first-page":"1355695","DOI":"10.3389\/fnins.2024.1355695","volume":"18","author":"R Mohanty","year":"2024","unstructured":"Mohanty R, Ferreira D, Westman E. Multi-pathological contributions toward atrophy patterns in the Alzheimer\u2019s disease continuum. Front Neurosci. 2024;18:1355695.","journal-title":"Front Neurosci"},{"issue":"10","key":"1768_CR62","doi-asserted-by":"publisher","first-page":"e26286","DOI":"10.1371\/journal.pone.0026286","volume":"6","author":"RJ Dawe","year":"2011","unstructured":"Dawe RJ, Bennett DA, Schneider JA, Arfanakis K. Neuropathologic correlates of hippocampal atrophy in the elderly: a clinical, pathologic, postmortem MRI study. PLoS ONE. 2011;6(10):e26286.","journal-title":"PLoS ONE"},{"key":"1768_CR63","doi-asserted-by":"crossref","unstructured":"Wu J, Su Y, Reiman EM, Caselli RJ, Chen K, Thompson PM et al. Investigating the Effect of Tau Deposition and Apoe on Hippocampal Morphometry in Alzheimer\u2019s Disease: A Federated Chow Test Model. Proc IEEE Int Symp Biomed Imaging. 2022;2022.","DOI":"10.1109\/ISBI52829.2022.9761576"},{"issue":"5","key":"1768_CR64","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1046\/j.1440-1819.2000.00747.x","volume":"54","author":"Y Fukutani","year":"2000","unstructured":"Fukutani Y, Cairns NJ, Shiozawa M, Sasaki K, Sudo S, Isaki K, et al. Neuronal loss and neurofibrillary degeneration in the hippocampal cortex in late-onset sporadic Alzheimer\u2019s disease. Psychiatry Clin Neurosci. 2000;54(5):523\u20139.","journal-title":"Psychiatry Clin Neurosci"},{"issue":"2","key":"1768_CR65","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.neurobiolaging.2005.02.008","volume":"27","author":"A von Gunten","year":"2006","unstructured":"von Gunten A, Kovari E, Bussiere T, Rivara CB, Gold G, Bouras C, et al. Cognitive impact of neuronal pathology in the entorhinal cortex and CA1 field in Alzheimer\u2019s disease. Neurobiol Aging. 2006;27(2):270\u20137.","journal-title":"Neurobiol Aging"},{"issue":"8","key":"1768_CR66","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.jalz.2018.02.020","volume":"14","author":"JL Whitwell","year":"2018","unstructured":"Whitwell JL, Graff-Radford J, Tosakulwong N, Weigand SD, Machulda MM, Senjem ML, et al. Imaging correlations of Tau, amyloid, metabolism, and atrophy in typical and atypical Alzheimer\u2019s disease. Alzheimers Dement. 2018;14(8):1005\u201314.","journal-title":"Alzheimers Dement"},{"issue":"12","key":"1768_CR67","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1212\/WNL.0b013e3181b879ac","volume":"73","author":"WJ Henneman","year":"2009","unstructured":"Henneman WJ, Vrenken H, Barnes J, Sluimer IC, Verwey NA, Blankenstein MA, et al. Baseline CSF p-tau levels independently predict progression of hippocampal atrophy in alzheimer disease. Neurology. 2009;73(12):935\u201340.","journal-title":"Neurology"},{"issue":"7","key":"1768_CR68","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1016\/j.neurobiolaging.2011.02.022","volume":"33","author":"LC de Souza","year":"2012","unstructured":"de Souza LC, Chupin M, Lamari F, Jardel C, Leclercq D, Colliot O, et al. CSF Tau markers are correlated with hippocampal volume in Alzheimer\u2019s disease. Neurobiol Aging. 2012;33(7):1253\u20137.","journal-title":"Neurobiol Aging"},{"issue":"12","key":"1768_CR69","doi-asserted-by":"publisher","first-page":"3376","DOI":"10.1111\/ejn.16361","volume":"59","author":"R Morais-Ribeiro","year":"2024","unstructured":"Morais-Ribeiro R, Almeida FC, Coelho A, Oliveira TG. Alzheimer\u2019s disease neuroimaging I. Differential atrophy along the longitudinal hippocampal axis in Alzheimer\u2019s disease. Eur J Neurosci. 2024;59(12):3376\u201388.","journal-title":"Eur J Neurosci"},{"issue":"9","key":"1768_CR70","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1002\/alz.12321","volume":"17","author":"CM Moloney","year":"2021","unstructured":"Moloney CM, Lowe VJ, Murray ME. Visualization of neurofibrillary tangle maturity in Alzheimer\u2019s disease: A clinicopathologic perspective for biomarker research. Alzheimers Dement. 2021;17(9):1554\u201374.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"1768_CR71","doi-asserted-by":"publisher","first-page":"e14355","DOI":"10.1002\/alz.14355","volume":"21","author":"K Yoshida","year":"2025","unstructured":"Yoshida K, Forrest SL, Ichimata S, Tanaka H, Kon T, Kovacs GG. Co-pathologies modify hippocampal protein accumulation patterns in neurodegenerative diseases. Alzheimer\u2019s Dement. 2025;21(1):e14355.","journal-title":"Alzheimer\u2019s Dement"},{"issue":"6","key":"1768_CR72","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1007\/s00401-022-02472-x","volume":"144","author":"S Arezoumandan","year":"2022","unstructured":"Arezoumandan S, Xie SX, Cousins KAQ, Mechanic-Hamilton DJ, Peterson CS, Huang CY, et al. Regional distribution and maturation of Tau pathology among phenotypic variants of Alzheimer\u2019s disease. Acta Neuropathol. 2022;144(6):1103\u201316.","journal-title":"Acta Neuropathol"},{"issue":"9","key":"1768_CR73","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/S1474-4422(11)70156-9","volume":"10","author":"ME Murray","year":"2011","unstructured":"Murray ME, Graff-Radford NR, Ross OA, Petersen RC, Duara R, Dickson DW. Neuropathologically defined subtypes of Alzheimer\u2019s disease with distinct clinical characteristics: a retrospective study. Lancet Neurol. 2011;10(9):785\u201396.","journal-title":"Lancet Neurol"},{"issue":"3","key":"1768_CR74","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1159\/000153432","volume":"26","author":"ER Kenny","year":"2008","unstructured":"Kenny ER, Burton EJ, O\u2019Brien JT. A volumetric magnetic resonance imaging study of entorhinal cortex volume in dementia with lewy bodies. A comparison with Alzheimer\u2019s disease and Parkinson\u2019s disease with and without dementia. Dement Geriatr Cogn Disord. 2008;26(3):218\u201325.","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"1","key":"1768_CR75","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1001\/archneur.59.1.102","volume":"59","author":"H Apaydin","year":"2002","unstructured":"Apaydin H, Ahlskog JE, Parisi JE, Boeve BF, Dickson DW. Parkinson disease neuropathology: later-developing dementia and loss of the Levodopa response. Arch Neurol. 2002;59(1):102\u201312.","journal-title":"Arch Neurol"},{"issue":"12","key":"1768_CR76","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1001\/archneurol.2011.725","volume":"68","author":"D Weintraub","year":"2011","unstructured":"Weintraub D, Doshi J, Koka D, Davatzikos C, Siderowf AD, Duda JE, et al. Neurodegeneration across stages of cognitive decline in Parkinson disease. Arch Neurol. 2011;68(12):1562\u20138.","journal-title":"Arch Neurol"},{"issue":"8","key":"1768_CR77","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1002\/hipo.22131","volume":"23","author":"JB Pereira","year":"2013","unstructured":"Pereira JB, Junque C, Bartres-Faz D, Ramirez-Ruiz B, Marti MJ, Tolosa E. Regional vulnerability of hippocampal subfields and memory deficits in Parkinson\u2019s disease. Hippocampus. 2013;23(8):720\u20138.","journal-title":"Hippocampus"},{"issue":"1","key":"1768_CR78","doi-asserted-by":"publisher","first-page":"15030","DOI":"10.1038\/npjparkd.2015.30","volume":"2","author":"AL Stav","year":"2016","unstructured":"Stav AL, Johansen KK, Auning E, Kalheim LF, Selnes P, Bj\u00f8rnerud A, et al. Hippocampal subfield atrophy in relation to cerebrospinal fluid biomarkers and cognition in early Parkinson\u2019s disease: a cross-sectional study. Npj Parkinson\u2019s Disease. 2016;2(1):15030.","journal-title":"Npj Parkinson\u2019s Disease"},{"issue":"5","key":"1768_CR79","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1002\/mds.20371","volume":"20","author":"C Junqu\u00e9","year":"2005","unstructured":"Junqu\u00e9 C, Ram\u00edrez-Ruiz B, Tolosa E, Summerfield C, Mart\u00ed MJ, Pastor P, et al. Amygdalar and hippocampal MRI volumetric reductions in Parkinson\u2019s disease with dementia. Mov Disord. 2005;20(5):540\u20134.","journal-title":"Mov Disord"},{"issue":"9","key":"1768_CR80","doi-asserted-by":"publisher","first-page":"e1514","DOI":"10.1002\/hsr2.1514","volume":"6","author":"M Yazdan Panah","year":"2023","unstructured":"Yazdan Panah M, Mokary Y, Shah S, Thapa S, Chand S, Shaygannejad V, et al. Comparing the hippocampal volumetric atrophy between demented and nondemented individuals with Parkinson\u2019s disease: A systematic review and meta-analysis. Health Sci Rep. 2023;6(9):e1514.","journal-title":"Health Sci Rep"},{"issue":"11","key":"1768_CR81","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1016\/j.parkreldis.2014.08.024","volume":"20","author":"N Kandiah","year":"2014","unstructured":"Kandiah N, Zainal NH, Narasimhalu K, Chander RJ, Ng A, Mak E, et al. Hippocampal volume and white matter disease in the prediction of dementia in Parkinson\u2019s disease. Parkinsonism Relat Disord. 2014;20(11):1203\u20138.","journal-title":"Parkinsonism Relat Disord"},{"issue":"6","key":"1768_CR82","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1136\/jnnp-2018-319592","volume":"90","author":"A Low","year":"2019","unstructured":"Low A, Foo H, Yong TT, Tan LCS, Kandiah N. Hippocampal subfield atrophy of CA1 and subicular structures predict progression to dementia in idiopathic Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry. 2019;90(6):681\u20137.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1768_CR83","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.neuroscience.2017.12.028","volume":"371","author":"F Novellino","year":"2018","unstructured":"Novellino F, Vasta R, Sarica A, Chiriaco C, Salsone M, Morelli M, et al. Relationship between hippocampal subfields and category cued recall in AD and PDD: A multimodal MRI study. Neuroscience. 2018;371:506\u201317.","journal-title":"Neuroscience"},{"issue":"5","key":"1768_CR84","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/s00401-009-0597-x","volume":"118","author":"ME Kalaitzakis","year":"2009","unstructured":"Kalaitzakis ME, Pearce RK. The morbid anatomy of dementia in Parkinson\u2019s disease. Acta Neuropathol. 2009;118(5):587\u201398.","journal-title":"Acta Neuropathol"},{"issue":"3","key":"1768_CR85","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.parkreldis.2008.05.007","volume":"15","author":"ME Kalaitzakis","year":"2009","unstructured":"Kalaitzakis ME, Christian LM, Moran LB, Graeber MB, Pearce RK, Gentleman SM. Dementia and visual hallucinations associated with limbic pathology in Parkinson\u2019s disease. Parkinsonism Relat Disord. 2009;15(3):196\u2013204.","journal-title":"Parkinsonism Relat Disord"},{"issue":"25","key":"1768_CR86","doi-asserted-by":"publisher","first-page":"2814","DOI":"10.1021\/acs.biochem.9b00215","volume":"58","author":"AKR Dasari","year":"2019","unstructured":"Dasari AKR, Kayed R, Wi S, Lim KH. Tau interacts with the C-Terminal region of \u03b1-Synuclein, promoting formation of toxic aggregates with distinct molecular conformations. Biochemistry. 2019;58(25):2814\u201321.","journal-title":"Biochemistry"},{"issue":"10","key":"1768_CR87","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1212\/WNL.54.10.1916","volume":"54","author":"HI Hurtig","year":"2000","unstructured":"Hurtig HI, Trojanowski JQ, Galvin J, Ewbank D, Schmidt ML, Lee VM, et al. Alpha-synuclein cortical lewy bodies correlate with dementia in Parkinson\u2019s disease. Neurology. 2000;54(10):1916\u201321.","journal-title":"Neurology"},{"issue":"3","key":"1768_CR88","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s004019900168","volume":"100","author":"PM Mattila","year":"2000","unstructured":"Mattila PM, Rinne JO, Helenius H, Dickson DW, Roytta M. Alpha-synuclein-immunoreactive cortical lewy bodies are associated with cognitive impairment in Parkinson\u2019s disease. Acta Neuropathol. 2000;100(3):285\u201390.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"1768_CR89","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13024-019-0320-x","volume":"14","author":"D Twohig","year":"2019","unstructured":"Twohig D, Nielsen HM. alpha-synuclein in the pathophysiology of Alzheimer\u2019s disease. Mol Neurodegener. 2019;14(1):23.","journal-title":"Mol Neurodegener"},{"issue":"1","key":"1768_CR90","doi-asserted-by":"publisher","first-page":"e20192193","DOI":"10.1084\/jem.20192193","volume":"218","author":"F Bassil","year":"2020","unstructured":"Bassil F, Meymand ES, Brown HJ, Xu H, Cox TO, Pattabhiraman S, et al. \u03b1-Synuclein modulates Tau spreading in mouse brains. J Exp Med. 2020;218(1):e20192193.","journal-title":"J Exp Med"},{"key":"1768_CR91","doi-asserted-by":"publisher","unstructured":"Struebing FL, De Vecchi T, Widmann J, Song X, Fierli F, Ruf V et al. Alpha-Synuclein co-pathology in Alzheimer\u2019s disease drives Tau accumulation. BioRxiv. 2025. https:\/\/doi.org\/10.1101\/2025.01.24.634706","DOI":"10.1101\/2025.01.24.634706"},{"issue":"4","key":"1768_CR92","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1002\/ana.23659","volume":"72","author":"DJ Irwin","year":"2012","unstructured":"Irwin DJ, White MT, Toledo JB, Xie SX, Robinson JL, Van Deerlin V, et al. Neuropathologic substrates of Parkinson disease dementia. Ann Neurol. 2012;72(4):587\u201398.","journal-title":"Ann Neurol"},{"issue":"3","key":"1768_CR93","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.jalz.2017.09.014","volume":"14","author":"TJ Ferman","year":"2018","unstructured":"Ferman TJ, Aoki N, Crook JE, Murray ME, Graff-Radford NR, van Gerpen JA, et al. The limbic and neocortical contribution of alpha-synuclein, Tau, and amyloid beta to disease duration in dementia with lewy bodies. Alzheimers Dement. 2018;14(3):330\u20139.","journal-title":"Alzheimers Dement"},{"issue":"3","key":"1768_CR94","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s00401-015-1526-9","volume":"131","author":"JB Toledo","year":"2016","unstructured":"Toledo JB, Gopal P, Raible K, Irwin DJ, Brettschneider J, Sedor S, et al. Pathological alpha-synuclein distribution in subjects with coincident Alzheimer\u2019s and lewy body pathology. Acta Neuropathol. 2016;131(3):393\u2013409.","journal-title":"Acta Neuropathol"},{"issue":"4","key":"1768_CR95","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1111\/bpa.12182","volume":"25","author":"DR Howlett","year":"2015","unstructured":"Howlett DR, Whitfield D, Johnson M, Attems J, O\u2019Brien JT, Aarsland D, et al. Regional multiple pathology scores are associated with cognitive decline in lewy body dementias. Brain Pathol. 2015;25(4):401\u20138.","journal-title":"Brain Pathol"},{"issue":"1","key":"1768_CR96","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s40478-019-0787-2","volume":"7","author":"ZA Sorrentino","year":"2019","unstructured":"Sorrentino ZA, Goodwin MS, Riffe CJ, Dhillon JS, Xia Y, Gorion KM, et al. Unique alpha-synuclein pathology within the amygdala in lewy body dementia: implications for disease initiation and progression. Acta Neuropathol Commun. 2019;7(1):142.","journal-title":"Acta Neuropathol Commun"},{"issue":"6","key":"1768_CR97","doi-asserted-by":"publisher","first-page":"e904","DOI":"10.1212\/WNL.0000000000011224","volume":"96","author":"S Becker","year":"2021","unstructured":"Becker S, Granert O, Timmers M, Pilotto A, Van Nueten L, Roeben B, et al. Association of hippocampal subfields, CSF biomarkers, and cognition in patients with Parkinson disease without dementia. Neurology. 2021;96(6):e904\u201315.","journal-title":"Neurology"},{"issue":"1","key":"1768_CR98","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s00401-024-02789-9","volume":"148","author":"AE Denning","year":"2024","unstructured":"Denning AE, Ittyerah R, Levorse LM, Sadeghpour N, Athalye C, Chung E, et al. Association of quantitative histopathology measurements with antemortem medial Temporal lobe cortical thickness in the Alzheimer\u2019s disease continuum. Acta Neuropathol. 2024;148(1):37.","journal-title":"Acta Neuropathol"},{"issue":"7","key":"1768_CR99","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1002\/alz.12249","volume":"17","author":"TM Harrison","year":"2021","unstructured":"Harrison TM, Du R, Klencklen G, Baker SL, Jagust WJ. Distinct effects of beta-amyloid and Tau on cortical thickness in cognitively healthy older adults. Alzheimers Dement. 2021;17(7):1085\u201396.","journal-title":"Alzheimers Dement"},{"key":"1768_CR100","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.dadm.2018.08.005","volume":"10","author":"E Mak","year":"2018","unstructured":"Mak E, Bethlehem RAI, Romero-Garcia R, Cervenka S, Rittman T, Gabel S, et al. In vivo coupling of Tau pathology and cortical thinning in Alzheimer\u2019s disease. Alzheimers Dement (Amst). 2018;10:678\u201387.","journal-title":"Alzheimers Dement (Amst)"},{"issue":"6","key":"1768_CR101","doi-asserted-by":"publisher","first-page":"e601","DOI":"10.1212\/WNL.0000000000006875","volume":"92","author":"R Ossenkoppele","year":"2019","unstructured":"Ossenkoppele R, Smith R, Ohlsson T, Strandberg O, Mattsson N, Insel PS, et al. Associations between Tau, Abeta, and cortical thickness with cognition in alzheimer disease. Neurology. 2019;92(6):e601\u201312.","journal-title":"Neurology"},{"issue":"4","key":"1768_CR102","doi-asserted-by":"publisher","first-page":"309","DOI":"10.2174\/1567205011666140302194358","volume":"11","author":"HA Crystal","year":"2014","unstructured":"Crystal HA, Schneider JA, Bennett DA, Leurgans S, Levine SR. Associations of cerebrovascular and Alzheimer\u2019s disease pathology with brain atrophy. Curr Alzheimer Res. 2014;11(4):309\u201316.","journal-title":"Curr Alzheimer Res"},{"issue":"1","key":"1768_CR103","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13195-020-00742-y","volume":"13","author":"RS O\u2019Dell","year":"2021","unstructured":"O\u2019Dell RS, Mecca AP, Chen MK, Naganawa M, Toyonaga T, Lu Y, et al. Association of Abeta deposition and regional synaptic density in early Alzheimer\u2019s disease: a PET imaging study with [(11)C]UCB-J. Alzheimers Res Ther. 2021;13(1):11.","journal-title":"Alzheimers Res Ther"},{"key":"1768_CR104","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.nbd.2013.02.005","volume":"54","author":"M Grand\u2019Maison","year":"2013","unstructured":"Grand\u2019Maison M, Zehntner SP, Ho M-K, H\u00e9bert F, Wood A, Carbonell F, et al. Early cortical thickness changes predict \u03b2-amyloid deposition in a mouse model of Alzheimer\u2019s disease. Neurobiol Dis. 2013;54:59\u201367.","journal-title":"Neurobiol Dis"},{"issue":"6","key":"1768_CR105","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1212\/01.WNL.0000115115.98960.37","volume":"62","author":"M Ingelsson","year":"2004","unstructured":"Ingelsson M, Fukumoto H, Newell KL, Growdon JH, Hedley-Whyte ET, Frosch MP, et al. Early Abeta accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain. Neurology. 2004;62(6):925\u201331.","journal-title":"Neurology"},{"key":"1768_CR106","doi-asserted-by":"crossref","unstructured":"Ferreira ST, Lourenco MV, Oliveira MM, De Felice FG. Soluble amyloid-b oligomers as synaptotoxins leading to cognitive impairment in Alzheimer\u2019s disease. Front Cell Neurosci. 2015;9:191.","DOI":"10.3389\/fncel.2015.00191"},{"issue":"4","key":"1768_CR107","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","volume":"14","author":"MT Heneka","year":"2015","unstructured":"Heneka MT, Carson MJ, Khoury JE, Landreth GE, Brosseron F, Feinstein DL, et al. Neuroinflammation in Alzheimer\u2019s disease. Lancet Neurol. 2015;14(4):388\u2013405.","journal-title":"Lancet Neurol"},{"issue":"12","key":"1768_CR108","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.3390\/cells11121885","volume":"11","author":"Y Rajesh","year":"2022","unstructured":"Rajesh Y, Kanneganti T-D. Innate immune cell death in neuroinflammation and Alzheimer\u2019s disease. Cells. 2022;11(12):1885.","journal-title":"Cells"},{"key":"1768_CR109","doi-asserted-by":"publisher","first-page":"578342","DOI":"10.1016\/j.jneuroim.2024.578342","volume":"390","author":"S Fruhw\u00fcrth","year":"2024","unstructured":"Fruhw\u00fcrth S, Zetterberg H, Paludan SR. Microglia and amyloid plaque formation in Alzheimer\u2019s disease\u2013 Evidence, possible mechanisms, and future challenges. J Neuroimmunol. 2024;390:578342.","journal-title":"J Neuroimmunol"},{"issue":"10","key":"1768_CR110","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1016\/j.neurobiolaging.2014.03.026","volume":"35","author":"CE Hanzel","year":"2014","unstructured":"Hanzel CE, Pichet-Binette A, Pimentel LSB, Iulita MF, Allard S, Ducatenzeiler A, et al. Neuronal driven pre-plaque inflammation in a Transgenic rat model of Alzheimer\u2019s disease. Neurobiol Aging. 2014;35(10):2249\u201362.","journal-title":"Neurobiol Aging"},{"key":"1768_CR111","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.neurobiolaging.2019.12.012","volume":"88","author":"L Batzu","year":"2020","unstructured":"Batzu L, Westman E, Pereira JB. Cerebrospinal fluid progranulin is associated with increased cortical thickness in early stages of Alzheimer\u2019s disease. Neurobiol Aging. 2020;88:61\u201370.","journal-title":"Neurobiol Aging"},{"issue":"9","key":"1768_CR112","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1212\/01.WNL.0000159743.08996.99","volume":"64","author":"NC Fox","year":"2005","unstructured":"Fox NC, Black RS, Gilman S, Rossor MN, Griffith SG, Jenkins L, et al. Effects of A\u03b2 immunization (AN1792) on MRI measures of cerebral volume in alzheimer disease. Neurology. 2005;64(9):1563\u201372.","journal-title":"Neurology"},{"issue":"11","key":"1768_CR113","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/S1474-4422(17)30284-3","volume":"16","author":"KA Josephs","year":"2017","unstructured":"Josephs KA, Dickson DW, Tosakulwong N, Weigand SD, Murray ME, Petrucelli L, et al. Rates of hippocampal atrophy and presence of post-mortem TDP-43 in patients with Alzheimer\u2019s disease: a longitudinal retrospective study. Lancet Neurol. 2017;16(11):917\u201324.","journal-title":"Lancet Neurol"},{"key":"1768_CR114","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neurobiolaging.2018.05.035","volume":"70","author":"A Llado","year":"2018","unstructured":"Llado A, Tort-Merino A, Sanchez-Valle R, Falgas N, Balasa M, Bosch B, et al. The hippocampal longitudinal axis-relevance for underlying Tau and TDP-43 pathology. Neurobiol Aging. 2018;70:1\u20139.","journal-title":"Neurobiol Aging"},{"issue":"6","key":"1768_CR115","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s00401-014-1269-z","volume":"127","author":"KA Josephs","year":"2014","unstructured":"Josephs KA, Whitwell JL, Weigand SD, Murray ME, Tosakulwong N, Liesinger AM, et al. TDP-43 is a key player in the clinical features associated with Alzheimer\u2019s disease. Acta Neuropathol. 2014;127(6):811\u201324.","journal-title":"Acta Neuropathol"},{"issue":"19 Pt 2","key":"1768_CR116","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1212\/01.wnl.0000304041.09418.b1","volume":"70","author":"KA Josephs","year":"2008","unstructured":"Josephs KA, Whitwell JL, Knopman DS, Hu WT, Stroh DA, Baker M, et al. Abnormal TDP-43 immunoreactivity in AD modifies clinicopathologic and radiologic phenotype. Neurology. 2008;70(19 Pt 2):1850\u20137.","journal-title":"Neurology"},{"issue":"1","key":"1768_CR117","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13024-021-00503-x","volume":"16","author":"A Meneses","year":"2021","unstructured":"Meneses A, Koga S, O\u2019Leary J, Dickson DW, Bu G, Zhao N. TDP-43 pathology in Alzheimer\u2019s disease. Mol Neurodegener. 2021;16(1):84.","journal-title":"Mol Neurodegener"},{"issue":"6","key":"1768_CR118","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1002\/alz.12079","volume":"16","author":"R de Flores","year":"2020","unstructured":"de Flores R, Wisse LEM, Das SR, Xie L, McMillan CT, Trojanowski JQ, et al. Contribution of mixed pathology to medial Temporal lobe atrophy in Alzheimer\u2019s disease. Alzheimers Dement. 2020;16(6):843\u201352.","journal-title":"Alzheimers Dement"},{"issue":"5","key":"1768_CR119","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1007\/s00401-021-02295-2","volume":"141","author":"SO Tome","year":"2021","unstructured":"Tome SO, Gomes LA, Li X, Vandenberghe R, Tousseyn T, Thal DR. TDP-43 interacts with pathological Tau protein in Alzheimer\u2019s disease. Acta Neuropathol. 2021;141(5):795\u20139.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"1768_CR120","doi-asserted-by":"publisher","first-page":"5950","DOI":"10.1038\/s41467-020-19786-7","volume":"11","author":"YH Shih","year":"2020","unstructured":"Shih YH, Tu LH, Chang TY, Ganesan K, Chang WW, Chang PS, et al. TDP-43 interacts with amyloid-beta, inhibits fibrillization, and worsens pathology in a model of Alzheimer\u2019s disease. Nat Commun. 2020;11(1):5950.","journal-title":"Nat Commun"},{"issue":"1","key":"1768_CR121","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s00401-009-0536-x","volume":"118","author":"T Arendt","year":"2009","unstructured":"Arendt T. Synaptic degeneration in Alzheimer\u2019s disease. Acta Neuropathol. 2009;118(1):167\u201379.","journal-title":"Acta Neuropathol"},{"issue":"9","key":"1768_CR122","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1007\/s00415-019-09400-2","volume":"266","author":"T Terada","year":"2019","unstructured":"Terada T, Yokokura M, Obi T, Bunai T, Yoshikawa E, Ando I, et al. In vivo direct relation of Tau pathology with neuroinflammation in early Alzheimer\u2019s disease. J Neurol. 2019;266(9):2186\u201396.","journal-title":"J Neurol"},{"key":"1768_CR123","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.inffus.2020.10.006","volume":"67","author":"L Su","year":"2021","unstructured":"Su L, Surendranathan A, Huang Y, Bevan-Jones WR, Passamonti L, Hong YT, et al. Relationship between Tau, neuroinflammation and atrophy in Alzheimer\u2019s disease: the NIMROD study. Inform Fusion. 2021;67:116\u201324.","journal-title":"Inform Fusion"},{"issue":"4","key":"1768_CR124","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","volume":"14","author":"MT Heneka","year":"2015","unstructured":"Heneka MT, Carson MJ, El Khoury J, Landreth GE, Brosseron F, Feinstein DL, et al. Neuroinflammation in Alzheimer\u2019s disease. Lancet Neurol. 2015;14(4):388\u2013405.","journal-title":"Lancet Neurol"},{"issue":"2","key":"1768_CR125","doi-asserted-by":"publisher","first-page":"e142","DOI":"10.1212\/WNL.0000000000008679","volume":"94","author":"L Yu","year":"2020","unstructured":"Yu L, Boyle PA, Dawe RJ, Bennett DA, Arfanakis K, Schneider JA. Contribution of TDP and hippocampal sclerosis to hippocampal volume loss in older-old persons. Neurology. 2020;94(2):e142\u201352.","journal-title":"Neurology"},{"issue":"3","key":"1768_CR126","doi-asserted-by":"publisher","first-page":"711","DOI":"10.3233\/JAD-2012-120928","volume":"32","author":"V Dhikav","year":"2012","unstructured":"Dhikav V, Anand KS. Are vascular factors linked to the development of hippocampal atrophy in Alzheimer\u2019s disease? J Alzheimers Dis. 2012;32(3):711\u20138.","journal-title":"J Alzheimers Dis"},{"key":"1768_CR127","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s12916-014-0206-2","volume":"12","author":"J Attems","year":"2014","unstructured":"Attems J, Jellinger KA. The overlap between vascular disease and Alzheimer\u2019s disease\u2013lessons from pathology. BMC Med. 2014;12:206.","journal-title":"BMC Med"},{"issue":"2","key":"1768_CR128","doi-asserted-by":"publisher","first-page":"309","DOI":"10.3233\/JAD-2011-110518","volume":"29","author":"BC Stephan","year":"2012","unstructured":"Stephan BC, Matthews FE, Ma B, Muniz G, Hunter S, Davis D, et al. Alzheimer and vascular neuropathological changes associated with different cognitive States in a non-demented sample. J Alzheimers Dis. 2012;29(2):309\u201318.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"1768_CR129","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/0197-4580(94)90143-0","volume":"15","author":"TH Vereecken","year":"1994","unstructured":"Vereecken TH, Vogels OJ, Nieuwenhuys R. Neuron loss and shrinkage in the amygdala in Alzheimer\u2019s disease. Neurobiol Aging. 1994;15(1):45\u201354.","journal-title":"Neurobiol Aging"},{"key":"1768_CR130","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.bbr.2017.07.003","volume":"334","author":"Y Yu","year":"2017","unstructured":"Yu Y, Feng L, Li J, Lan X, Lv AL. The alteration of autophagy and apoptosis in the hippocampus of rats with natural aging-dependent cognitive deficits. Behav Brain Res. 2017;334:155\u201362.","journal-title":"Behav Brain Res"},{"key":"1768_CR131","unstructured":"Witter MP. Anatomical Organization."},{"issue":"7","key":"1768_CR132","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1016\/j.neurobiolaging.2008.08.008","volume":"31","author":"LG Apostolova","year":"2010","unstructured":"Apostolova LG, Mosconi L, Thompson PM, Green AE, Hwang KS, Ramirez A, et al. Subregional hippocampal atrophy predicts Alzheimer\u2019s dementia in the cognitively normal. Neurobiol Aging. 2010;31(7):1077\u201388.","journal-title":"Neurobiol Aging"},{"issue":"4","key":"1768_CR133","doi-asserted-by":"publisher","first-page":"747","DOI":"10.3174\/ajnr.A3293","volume":"34","author":"HK Lim","year":"2013","unstructured":"Lim HK, Hong SC, Jung WS, Ahn KJ, Won WY, Hahn C, et al. Automated segmentation of hippocampal subfields in drug-naive patients with alzheimer disease. AJNR Am J Neuroradiol. 2013;34(4):747\u201351.","journal-title":"AJNR Am J Neuroradiol"},{"issue":"6","key":"1768_CR134","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.neurobiolaging.2003.09.009","volume":"25","author":"B Schonheit","year":"2004","unstructured":"Schonheit B, Zarski R, Ohm TG. Spatial and Temporal relationships between plaques and tangles in Alzheimer-pathology. Neurobiol Aging. 2004;25(6):697\u2013711.","journal-title":"Neurobiol Aging"},{"issue":"1","key":"1768_CR135","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/hipo.22671","volume":"27","author":"LEM Wisse","year":"2017","unstructured":"Wisse LEM, Daugherty AM, Olsen RK, Berron D, Carr VA, Stark CEL, et al. A harmonized segmentation protocol for hippocampal and parahippocampal subregions: why do we need one and what are the key goals? Hippocampus. 2017;27(1):3\u201311.","journal-title":"Hippocampus"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-025-01768-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-025-01768-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-025-01768-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T08:04:07Z","timestamp":1748592247000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-025-01768-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,30]]},"references-count":135,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1768"],"URL":"https:\/\/doi.org\/10.1186\/s13195-025-01768-w","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,30]]},"assertion":[{"value":"18 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All donors signed a written informed consent for brain donation and the use of their brain issue and medical records for research purposes. The procedures for brain tissue collection of NBB and NABCA have been approved by the Medical Ethical Committee of Amsterdam UMC, Vrije Universiteit Amsterdam.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"WvdB performed contract research for Roche Tissue Diagnostics and Discoveric Bio, received antibodies for research purposed from Hoffmann-La Roche and Prothena. She is a member of the scientific advisory board of Gain Therapeutics. LEJ performs contract research for Imeka.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"121"}}